Xencor, Inc.

Technology for MHC epitope removal, glycosylation to optimize pharmacokinetics, masking immune recognition sites and engineering monoclonal antibodies. Includes discovery programs, partnering opportunities in Monrovia, California. ImmunoPDAâ„¢ Technology Product Sheet Caltech spin-off developing proteomic technologies to accelerate drug discovery.